Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionADAR1 Capital Management, LLC
Latest Disclosed Ownership262,058 shares
Latest Disclosed Value $ 5,702,382
ADAR1 Capital Management, LLC ownership in SRPT / Sarepta Therapeutics, Inc.

On May 16, 2026 - ADAR1 Capital Management, LLC filed a 13F-HR form disclosing ownership of 262,058 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $5,702,382 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 18, 2026 disclosing 28,866 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 807.84% during the quarter.

ADAR1 Capital Management, LLC has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-16 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 262,058 233,192 807.84 5,702 818.20 0.3353
2026-02-18 2025-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 28,866 -320,941 -91.75 621 -90.79 0.0456
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 28,866 -320,941 621 0.0450
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 349,807 139,494 66.33 6,741 87.43 0.6332
2025-08-14 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 210,313 87,392 71.10 3,596 -54.16 0.5515
2025-05-15 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 122,921 82,919 207.29 7,845 61.30 1.4563
2025-02-13 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 40,002 32,902 463.41 4,864 448.87 0.9720
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 7,100 2,650 59.55 887 26.03 0.1442
2024-08-13 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 4,450 -26,655 -85.69 703 -82.54 0.1327
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 31,105 23,043 285.82 4,027 418.15 0.9136
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 8,062 8,062 777 0.2778
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F SAREPTA THERAPEUTICS COM Call 55,000 940 n/a n/a n/a
2024-08-13 2024-06-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM Call 1,200 155 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.